Literature DB >> 22378503

EF24 suppresses maturation and inflammatory response in dendritic cells.

Prachi Vilekar1, Shanjana Awasthi, Aravindan Natarajan, Shrikant Anant, Vibhudutta Awasthi.   

Abstract

Synthetic curcuminoid EF24 was studied for its effect on the maturation and inflammatory response in murine bone marrow derived immortalized JAWS II dendritic cells (DCs). EF24 reduced the expression of LPS-induced MHC class II, CD80 and CD86 molecules. It also abrogated the appearance of dendrites, a typical characteristic of mature DCs. These effects were accompanied by the inhibition of LPS-induced activation of transcription factor nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB). Simultaneous reduction of pro-inflammatory cytokines [tumor necrosis factor (TNF)-α, IL-6] both at the mRNA and secreted levels was also observed. To investigate the dependency of LPS effects on MyD88 adaptor protein, we transfected JAWS II DCs with dominant negative MyD88 plasmid construct (MyD88-DN). EF24 reduced NF-κB activity and TNF-α secretion in a MyD88-dependent manner. These results suggest that EF24 modulates DCs by suppressing their maturation and reducing the secretion of inflammatory cytokines. Further, it appears that EF24 acts at or upstream of MyD88 in the LPS-TLR4/MyD88/NF-κB pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22378503      PMCID: PMC3385421          DOI: 10.1093/intimm/dxr121

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  39 in total

Review 1.  NF-kappaB and the regulation of hematopoiesis.

Authors:  V Bottero; S Withoff; I M Verma
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

Review 2.  Complexities of targeting innate immunity to treat infection.

Authors:  Kelly L Brown; Céline Cosseau; Jennifer L Gardy; Robert E W Hancock
Journal:  Trends Immunol       Date:  2007-04-30       Impact factor: 16.687

Review 3.  Dendritic cells and cytokines in human inflammatory and autoimmune diseases.

Authors:  Patrick Blanco; A Karolina Palucka; Virginia Pascual; Jacques Banchereau
Journal:  Cytokine Growth Factor Rev       Date:  2008-02       Impact factor: 7.638

4.  Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response.

Authors:  Stefanie B Flohé; Hemant Agrawal; Daniel Schmitz; Michaela Gertz; Sascha Flohé; F Ulrich Schade
Journal:  J Leukoc Biol       Date:  2005-12-19       Impact factor: 4.962

5.  Inhibition of homodimerization of Toll-like receptor 4 by curcumin.

Authors:  Hyung S Youn; Shin I Saitoh; Kensuke Miyake; Daniel H Hwang
Journal:  Biochem Pharmacol       Date:  2006-04-01       Impact factor: 5.858

Review 6.  Bioavailability of curcumin: problems and promises.

Authors:  Preetha Anand; Ajaikumar B Kunnumakkara; Robert A Newman; Bharat B Aggarwal
Journal:  Mol Pharm       Date:  2007-11-14       Impact factor: 4.939

Review 7.  Highly active anticancer curcumin analogues.

Authors:  Cara A Mosley; Dennis C Liotta; James P Snyder
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

8.  Airway dendritic cell phenotypes in inflammatory diseases of the human lung.

Authors:  M Lommatzsch; K Bratke; A Bier; P Julius; M Kuepper; W Luttmann; J C Virchow
Journal:  Eur Respir J       Date:  2007-07-11       Impact factor: 16.671

9.  MD-2 as the target of curcumin in the inhibition of response to LPS.

Authors:  Helena Gradisar; Mateja Mancek Keber; Primoz Pristovsek; Roman Jerala
Journal:  J Leukoc Biol       Date:  2007-07-03       Impact factor: 4.962

Review 10.  Curcumin: from ancient medicine to current clinical trials.

Authors:  H Hatcher; R Planalp; J Cho; F M Torti; S V Torti
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

View more
  17 in total

1.  Pharmacologic suppression of inflammation by a diphenyldifluoroketone, EF24, in a rat model of fixed-volume hemorrhage improves survival.

Authors:  Vivek R Yadav; Kaustuv Sahoo; Pamela R Roberts; Vibhudutta Awasthi
Journal:  J Pharmacol Exp Ther       Date:  2013-08-30       Impact factor: 4.030

2.  Anti-inflammatory mediators ST2 and SIGIRR are induced by diphenyldifluoroketone EF24 in lipopolysaccharide-stimulated dendritic cells.

Authors:  Vibhudutta Awasthi; Prachi Vilekar; Geeta Rao; Shanjana Awasthi
Journal:  Immunobiology       Date:  2019-11-29       Impact factor: 3.144

3.  Toll-like receptor 4-interacting SPA4 peptide suppresses the NLRP3 inflammasome in response to LPS and ATP stimuli.

Authors:  Vijay Ramani; Shanjana Awasthi
Journal:  J Leukoc Biol       Date:  2015-08-07       Impact factor: 4.962

4.  Hemorrhage-induced interleukin-1 receptor pathway in lung is suppressed by 3,5-bis(2-fluorobenzylidene)-4-piperidone in a rat model of hypovolemic shock.

Authors:  Vivek R Yadav; Prachi Vilekar; Shanjana Awasthi; Vibhudutta Awasthi
Journal:  Artif Organs       Date:  2014-04-22       Impact factor: 3.094

5.  Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft.

Authors:  Vivek R Yadav; Kaustuv Sahoo; Vibhudutta Awasthi
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

6.  Hemorrhagic shock-induced cerebral bioenergetic imbalance is corrected by pharmacologic treatment with EF24 in a rat model.

Authors:  Geeta Rao; Jun Xie; Andria Hedrick; Vibhudutta Awasthi
Journal:  Neuropharmacology       Date:  2015-07-29       Impact factor: 5.250

7.  Remediation of hemorrhagic shock-induced intestinal barrier dysfunction by treatment with diphenyldihaloketones EF24 and CLEFMA.

Authors:  Vivek R Yadav; Alamdar Hussain; Kaustuv Sahoo; Vibhudutta Awasthi
Journal:  J Pharmacol Exp Ther       Date:  2014-09-09       Impact factor: 4.030

8.  The salutary effects of diphenyldifluoroketone EF24 in liver of a rat hemorrhagic shock model.

Authors:  Vivek R Yadav; Alamdar Hussain; Jun Xie; Stanley Kosanke; Vibhudutta Awasthi
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2015-02-03       Impact factor: 2.953

9.  Molecular basis of 'hypoxic' breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling.

Authors:  Sheeja Aravindan; Mohan Natarajan; Terence S Herman; Vibhudutta Awasthi; Natarajan Aravindan
Journal:  Radiat Oncol       Date:  2013-03-04       Impact factor: 3.481

10.  Diphenyldifluoroketone EF24 Suppresses Pro-inflammatory Interleukin-1 receptor 1 and Toll-like Receptor 4 in lipopolysaccharide-stimulated dendritic cells.

Authors:  Prachi Vilekar; Geeta Rao; Shanjana Awasthi; Vibhudutta Awasthi
Journal:  J Inflamm (Lond)       Date:  2015-09-23       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.